Program Overview
The symposium includes lectures on the latest and advanced therapies in pediatric solid tumors, leukemias, and lymphomas (immunotherapies, antibody-based therapies …etc.) to improve the outcomes of pediatric hematology-oncology patients. In addition to panel discussions on challenges of applying novel treatments in Leukemias, lymphomas, and solid tumors in resource-limited settings.
Target Audience
This activity is designed for physicians, scientists, and healthcare professionals involved in childhood cancer care and research.
This activity has been approved for AMA PRA Category 1 CreditTM.
This activity is organized by the AUBMC Continuing Medical Education (CME) Office.
